https://www.selleckchem.com/products/bay-293.html
714, 95% confidence interval (95%CI) 1.114-2.638], MACEs (HR 1.354, 95%CI 1.024-1.79, all-cause death (HR 1.804, 95%CI 1.286-2.532) and cardiac death (HR 1.891, 95%CI 1.112-3.217). Furthermore, adding lipoprotein(a) to the prognostic model for hard CHD events improved the C-statistic value (P 0.05). Elevated lipoprotein(a) levels were associated with an increased risk of hard CHD events, MACEs, all-cause death and cardiac death in the advanced-age patients with ACS, which indicated that routine screening for lipoprotein(a) might